Current Management of Atherosclerotic Renovascular Disease – What Have We Learned from ASTRAL?

Publisher： Karger

E-ISSN： 1660-2110|115|1|c73-c81

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.115, Iss.1, 2010-02, pp. : c73-c81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What We Have Learned From a Decade of ED Crowding Research

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 8, 2015-08 ,pp. : 985-987

John Wiley & Sons Inc

Access to resources Recommend Favorite

Contralateral biopsy in the management of testicular cancer: what we have learned and what we need to improve

By  

ANDROLOGY, Vol. 3, Iss. 1, 2015-01 ,pp. : 99-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibiotic resistance: what have we learned and where do we go from here?

By Blondeau Joseph  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 751-753

Future Medicine

Access to resources Recommend Favorite

Infant body composition in the PEA POD® era: what have we learned and where do we go from here?

By  

Journal of Developmental Origins of Health and Disease, Vol. 4, Iss. 2, 2012-11 ,pp. : 116-120

Cambridge University Press

Access to resources Recommend Favorite

Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies?

By Morty Rory   Eickelberg Oliver   Seeger Werner  

Intensive Care Medicine, Vol. 33, Iss. 7, 2007-07 ,pp. : 1229-1240

Springer Publishing Company

Access to resources Recommend Favorite